A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

Clinical trial NCT05902988 · RECRUITING

Trial details

NCT number: NCT05902988
Sponsor: Volastra Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor High Grade Serous Adenocarcinoma of Ovary Squamous Non-small-cell Lung Cancer Triple Negative Breast Cancer Head and Neck Squamous Cell Carcinoma Ovarian Carcinosarcoma Uterine Carcinosarcoma Uterine Serous Carcinoma Endometrium Cancer Chromosomal Instability

Start date: 2023-10-18
Primary completion: 2026-06-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.